|
1
|
Pihlstrom BL, Michalowicz BS and Johnson
NW: Periodontal diseases. Lancet. 366:1809–1820. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eke PI, Dye BA, Wei L, Thornton-Evans GO
and Genco RJ; CDC Periodontal Disease Surveillance workgroup, :
James Beck (University of North Carolina, Chapel Hill, USA), Gordon
Douglass (Past President, American Academy of Periodontology), Roy
Page (University of Washin: Prevalence of periodontitis in adults
in the United States: 2009 and 2010. J Dent Res. 91:914–920. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Preshaw PM, Alba AL, Herrera D, Jepsen S,
Konstantinidis A, Makrilakis K and Taylor R: Periodontitis and
diabetes: A two-way relationship. Diabetologia. 55:21–31. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanz M, Ceriello A, Buysschaert M, Chapple
I, Demmer RT, Graziani F, Herrera D, Jepsen S, Lione L, Madianos P,
et al: Scientific evidence on the links between periodontal
diseases and diabetes: Consensus report and guidelines of the joint
workshop on periodontal diseases and diabetes by the International
Diabetes Federation and the European Federation of Periodontology.
J Clin Periodontol. 45:138–149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polak D and Shapira L: An update on the
evidence for pathogenic mechanisms that may link periodontitis and
diabetes. J Clin Periodontol. 45:150–166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hajishengallis G: Periodontitis: From
microbial immune subversion to systemic inflammation. Nat Rev
Immunol. 15:30–44. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bohannon JK, Hernandez A, Enkhbaatar P,
Adams WL and Sherwood ER: The immunobiology of toll-like receptor 4
agonists: From endotoxin tolerance to immunoadjuvants. Shock.
40:451–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suda K, Udagawa N, Sato N, Takami M, Itoh
K, Woo JT, Takahashi N and Nagai K: Suppression of osteoprotegerin
expression by prostaglandin E2 is crucially involved in
lipopolysaccharide-induced osteoclast formation. J Immunol.
172:2504–2510. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takatsuna H, Kato H, Gohda J, Akiyama T,
Moriya A, Okamoto Y, Yamagata Y, Otsuka M, Umezawa K, Semba K and
Inoue J: Identification of TIFA as an adapter protein that links
tumor necrosis factor receptor-associated factor 6 (TRAF6) to
interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1
receptor signaling. J Biol Chem. 278:12144–12150. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen W, Chang A, Wang J, Zhou W, Gao R, Li
J, Xu Y, Luo X, Xiang R, Luo N and Stupack DG: TIFA, an
inflammatory signaling adaptor, is tumor suppressive for liver
cancer. Oncogenesis. 4:e1732015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen W, Du R, Li J, Luo X, Zhao S, Chang
A, Zhou W, Gao R, Luo D, Wang J, et al: TIFA suppresses
hepatocellular carcinoma progression via MALT1-dependent and
-independent signaling pathways. Signal Transduct Target Ther.
1:160132016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zimmermann S, Pfannkuch L, Al-Zeer MA,
Bartfeld S, Koch M, Liu J, Rechner C, Soerensen M, Sokolova O,
Zamyatina A, et al: ALPK1- and TIFA-Dependent Innate immune
response triggered by the helicobacter pylori type IV secretion
system. Cell Rep. 20:2384–2395. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Milivojevic M, Dangeard AS, Kasper CA,
Tschon T, Emmenlauer M, Pique C, Schnupf P, Guignot J and
Arrieumerlou C: ALPK1 controls TIFA/TRAF6-dependent innate immunity
against heptose-1,7-bisphosphate of gram-negative bacteria. PLoS
Pathog. 13:e10062242017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin TY, Wei TW, Li S, Wang SC, He M,
Martin M, Zhang J, Shentu TP, Xiao H, Kang J, et al: TIFA as a
crucial mediator for NLRP3 inflammasome. Proc Natl Acad Sci USA.
113:15078–15083. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jimi E and Ghosh S: Role of nuclear
factor-kappaB in the immune system and bone. Immunol Rev.
208:80–87. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayden MS and Ghosh S: Regulation of NF-κB
by TNF family cytokines. Semin Immunol. 26:253–266. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guan X, He Y, Wei Z, Shi C, Li Y, Zhao R,
Pan L, Han Y, Hou T and Yang J: Crosstalk between Wnt/β-catenin
signaling and NF-κB signaling contributes to apical periodontitis.
Int Immunopharmacol. 98:1078432021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian Y, Li Y, Liu J, Lin Y, Jiao J, Chen
B, Wang W, Wu S and Li C: Photothermal therapy with regulated
Nrf2/NF-κB signaling pathway for treating bacteria-induced
periodontitis. Bioact Mater. 9:428–445. 2021.PubMed/NCBI
|
|
19
|
Odes-Barth S, Khanin M, Linnewiel-Hermoni
K, Miller Y, Abramov K, Levy J and Sharoni Y: Inhibition of
osteoclast differentiation by carotenoid derivatives through
inhibition of the NF-ƙB pathway. Antioxidants (Basel). 9:11672020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lalla E, Lamster IB, Feit M, Huang L,
Spessot A, Qu W, Kislinger T, Lu Y, Stern DM and Schmidt AM:
Blockade of RAGE suppresses periodontitis-associated bone loss in
diabetic mice. J Clin Invest. 105:1117–1124. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krongbaramee T, Zhu M, Qian Q, Zhang Z,
Eliason S, Shu Y, Qian F, Akkouch A, Su D, Amendt BA, et al:
Plasmid encoding microRNA-200c ameliorates periodontitis and
systemic inflammation in obese mice. Mol Ther Nucleic Acids.
23:1204–1216. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press (US); Washington, DC: 2011
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bauer M, Nascakova Z, Mihai AI, Cheng PF,
Levesque MP, Lampart S, Hurwitz R, Pfannkuch L, Dobrovolna J,
Jacobs M, et al: The ALPK1/TIFA/NF-κB axis links a bacterial
carcinogen to R-loop-induced replication stress. Nat Commun.
11:51172020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fuller K, Lawrence KM, Ross JL, Grabowska
UB, Shiroo M, Samuelsson B and Chambers TJ: Erratum to ‘Cathepsin K
inhibitors prevent matrix-derived growth factor degradation by
human osteoclasts’. Bone. 145:1153542021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sundaram K, Nishimura R, Senn J, Youssef
RF, London SD and Reddy SV: RANK ligand signaling modulates the
matrix metalloproteinase-9 gene expression during osteoclast
differentiation. Exp Cell Res. 313:168–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Preshaw PM: Periodontal disease and
diabetes. J Dent. 37:S575–S577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kinane DF: Causation and pathogenesis of
periodontal disease. Periodontol 2000. 25:8–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Dyke TE and Serhan CN: Resolution of
inflammation: A new paradigm for the pathogenesis of periodontal
diseases. J Dent Res. 82:82–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhen L, Fan DS, Zhang Y, Cao XM and Wang
LM: Resveratrol ameliorates experimental periodontitis in diabetic
mice through negative regulation of TLR4 signaling. Acta Pharmacol
Sin. 36:221–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hayata M, Watanabe N, Kamio N, Tamura M,
Nodomi K, Tanaka K, Iddamalgoda A, Tsuda H, Ogata Y, Sato S, et al:
Cynaropicrin from Cynara scolymus L. suppresses Porphyromonas
gingivalis LPS-induced production of inflammatory cytokines in
human gingival fibroblasts and RANKL-induced osteoclast
differentiation in RAW264.7 cells. J Nat Med. 73:114–123. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu J, Huang D, Yuan F, Xie N, Li Q, Sun X,
Zhou X, Li G, Tong T and Zhang Y: TRAF-interacting protein with
forkhead-associated domain (TIFA) transduces DNA damage-induced
activation of NF-κB. J Biol Chem. 293:7268–7280. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang HC, Wei TW, Wu PY, Tsai MD, Yu WC,
Chen CH and Sung SH: TIFA protein expression is associated with
pulmonary arterial hypertension. Sci Rep. 11:141402021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Müller AK, Albrecht F, Rohrer C, Koeberle
A, Werz O, Schlörmann W, Glei M, Lorkowski S and Wallert M: Olive
Oil extracts and oleic acid attenuate the LPS-Induced inflammatory
response in murine RAW264.7 macrophages but induce the release of
prostaglandin E2. Nutrients. 13:44372021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li JY, Zheng ZX, Liu L, Du O, Yu NW, Zou
Y, Seong SY and Du JR: Neuroprotective effect of alpha-kinase 1
knockdown against cerebral ischemia through inhibition of the NF-κB
pathway and neuroinflammation. Int Immunopharmacol. 113((Pt A)):
1093302022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Snelling T, Shpiro N, Gourlay R,
Lamoliatte F and Cohen P: Co-ordinated control of the
ADP-heptose/ALPK1 signalling network by the E3 ligases TRAF6,
TRAF2/c-IAP1 and LUBAC. Biochem J. 479:2195–2216. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I,
Taniguchi S, Sagara J, Fernandes-Alnemri T and Alnemri ES:
Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC
oligomerization. Cell Death Differ. 13:236–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fernandes-Alnemri T, Wu J, Yu JW, Datta P,
Miller B, Jankowski W, Rosenberg S, Zhang J and Alnemri ES: The
pyroptosome: A supramolecular assembly of ASC dimers mediating
inflammatory cell death via caspase-1 activation. Cell Death
Differ. 14:1590–1604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roodman GD: Cell biology of the
osteoclast. Exp Hematol. 27:1229–1241. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Teitelbaum SL: Bone resorption by
osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He Y, Zhang Q, Shen Y, Chen X, Zhou F and
Peng D: Schisantherin A suppresses osteoclast formation and wear
particle-induced osteolysis via modulating RANKL signaling
pathways. Biochem Biophys Res Commun. 449:344–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song C, Yang X, Lei Y, Zhang Z, Smith W,
Yan J and Kong L: Evaluation of efficacy on RANKL induced
osteoclast from RAW264.7 cells. J Cell Physiol. 234:11969–11975.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ,
Yun J, Lee CW, Nam KH, Kim Y, Han SB, et al: Agelasine D suppresses
RANKL-induced osteoclastogenesis via down-regulation of c-Fos,
NFATc1 and NF-κB. Mar Drugs. 12:5643–5656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li X, Jiang J, Yang Z, Jin S, Lu X and
Qian Y: Galangin suppresses RANKL-induced osteoclastogenesis via
inhibiting MAPK and NF-κB signalling pathways. J Cell Mol Med.
25:4988–5000. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu L, Luo Z and Liu Y, Jia L, Jiang Y, Du
J, Guo L, Bai Y and Liu Y: Aspirin inhibits RANKL-induced
osteoclast differentiation in dendritic cells by suppressing NF-κB
and NFATc1 activation. Stem Cell Res Ther. 10:3752019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zenger S, Hollberg K, Ljusberg J, Norgård
M, Ek-Rylander B, Kiviranta R and Andersson G: Proteolytic
processing and polarized secretion of tartrate-resistant acid
phosphatase is altered in a subpopulation of metaphyseal
osteoclasts in cathepsin K-deficient mice. Bone. 41:820–832. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Takayanagi H: The role of NFAT in
osteoclast formation. Ann N Y Acad Sci. 1116:227–237. 2007.
View Article : Google Scholar : PubMed/NCBI
|
